VNDA - Vanda Pharmaceuticals Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue146,017109,92550,157
Cost of Revenue24,71223,4621,583
Gross Profit121,30586,46348,574
Operating Expenses
Research Development29,15629,14519,230
Selling General and Administrative99,78784,53184,644
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-18,571-40,18520,062
Income from Continuing Operations
Total Other Income/Expenses Net66532077,740
Earnings Before Interest and Taxes-17,906-39,86520,186
Interest Expense---
Income Before Tax-17,906-39,86520,186
Income Tax Expense104--
Minority Interest---
Net Income From Continuing Ops-18,010-39,86520,186
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-18,010-39,86520,186
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-18,010-39,86520,186